相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recent Advancement in Nanotechnology-Based Drug Delivery System Against Viral Infections
Deepak Pradhan et al.
AAPS PHARMSCITECH (2021)
Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit?
Lene H. Garvey et al.
BRITISH JOURNAL OF ANAESTHESIA (2021)
COVID-19 vaccines: where we stand and challenges ahead
Guido Forni et al.
CELL DEATH AND DIFFERENTIATION (2021)
Next-Generation Vaccines: Nanoparticle-Mediated DNA and mRNA Delivery
William Ho et al.
ADVANCED HEALTHCARE MATERIALS (2021)
Prolonged Codelivery of Hemagglutinin and a TLR7/8 Agonist in a Supramolecular Polymer-Nanoparticle Hydrogel Enhances Potency and Breadth of Influenza Vaccination
Gillie A. Roth et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2021)
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
Piyada Supasa et al.
CELL (2021)
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
Daming Zhou et al.
CELL (2021)
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
Xiaoying Shen et al.
CELL HOST & MICROBE (2021)
Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID-19 vaccine
Priya Sellaturay et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2021)
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
Katherine R. W. Emary et al.
LANCET (2021)
Applications and practice of advanced drug delivery systems for targeting Toll-like receptors in pulmonary diseases
Yinghan Chan et al.
NANOMEDICINE (2021)
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
S. A. Madhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development
Yingzhu Li et al.
ACS CENTRAL SCIENCE (2021)
Endosomes and Microtubles are Required for Productive Infection in Aquareovirus
Fuxian Zhang et al.
VIROLOGICA SINICA (2020)
Respiratory Virus Infections: Understanding COVID-19
Kanta Subbarao et al.
IMMUNITY (2020)
Current development of COVID-19 diagnostics, vaccines and therapeutics
Naru Zhang et al.
MICROBES AND INFECTION (2020)
Coronavirus Disease 2019-COVID-19
Kuldeep Dhama et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology
Aleksandra Zielinska et al.
MOLECULES (2020)
Alginate Nanoformulation: Influence of Process and Selected Variables
Hazem Choukaife et al.
PHARMACEUTICALS (2020)
The Impact of Nanoparticles on Innate Immune Activation by Live Bacteria
Benjamin J. Swartzwelter et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Advanced drug delivery systems can assist in managing influenza virus infection: A hypothesis
Yinghan Chan et al.
MEDICAL HYPOTHESES (2020)
Organic and inorganic nanoparticle vaccines for prevention of infectious diseases
Christopher Poon et al.
NANO EXPRESS (2020)
Nanoparticle formulated vaccines: opportunities and challenges
Pingsai Lung et al.
NANOSCALE (2020)
Nanoparticle-based delivery platforms for mRNA vaccine development
Sezer Okay et al.
AIMS BIOPHYSICS (2020)
Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19
Naidi Yang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Exploitation of Cytoskeletal Networks during Early Viral Infection
Derek Walsh et al.
TRENDS IN MICROBIOLOGY (2019)
Preparation, characterization and in vivo evaluation of alginate-coated chitosan and trimethylchitosan nanoparticles loaded with PR8 influenza virus for nasal immunization
Jafar Mosafer et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Airway macrophages as the guardians of tissue repair in the lung
Franz Puttur et al.
IMMUNOLOGY AND CELL BIOLOGY (2019)
Current and future influenza vaccines
Seiya Yamayoshi et al.
NATURE MEDICINE (2019)
Biodegradable polymers for modern vaccine development
Rajendran J. C. Bose et al.
JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY (2019)
Mucosal vaccines and technology
A. Miquel-Clopes et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)
Chitosan alters inactivated respiratory syncytial virus vaccine elicited immune responses without affecting lung histopathology in mice
Abenaya Muralidharan et al.
VACCINE (2019)
Use of Biopolymers in Mucosally-Administered Vaccinations for Respiratory Disease
Margaret R. Dedloff et al.
MATERIALS (2019)
Mucosal Vaccination via the Respiratory Tract
Marie Hellfritzsch et al.
PHARMACEUTICS (2019)
Exploiting PLGA-Based Biocompatible Nanoparticles for Next-Generation Tolerogenic Vaccines against Autoimmune Disease
Giuseppe Cappellano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines
Zheng Jin et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Influenza virus-related critical illness: pathophysiology and epidemiology
Andre C. Kalil et al.
CRITICAL CARE (2019)
Respiratory syncytial virus infections
M. Wetzke et al.
PNEUMOLOGE (2019)
Nanoparticle-Based Vaccines Against Respiratory Viruses
Soultan Al-Halifa et al.
FRONTIERS IN IMMUNOLOGY (2019)
Virus Entry: Looking Back and Moving Forward
Ari Helenius
JOURNAL OF MOLECULAR BIOLOGY (2018)
Preparation, characterization and immunological evaluation of alginate nanoparticles loaded with whole inactivated influenza virus: Dry powder formulation for nasal immunization in rabbits
Solmaz Dehghan et al.
MICROBIAL PATHOGENESIS (2018)
Nasal vaccination with r4M2e.HSP70c antigen encapsulated into N-trimethyl chitosan (TMC) nanoparticulate systems: Preparation and immunogenicity in a mouse model
Mehran Dabaghian et al.
VACCINE (2018)
Influenza vaccines: Evaluation of the safety profile
Claudia Maria Trombetta et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Polymer-Based Nanomaterials and Applications for Vaccines and Drugs
Jinyu Han et al.
POLYMERS (2018)
Chitosan and Its Derivatives for Application in Mucoadhesive Drug Delivery Systems
Twana Mohammed M. Ways et al.
POLYMERS (2018)
Respiratory Mononuclear Phagocytes in Human influenza A virus infection: Their Role in immune Protection and As Targets of the virus
Sindhu Vangeti et al.
FRONTIERS IN IMMUNOLOGY (2018)
Virus-mimetic polymer nanoparticles displaying hemagglutinin as an adjuvant-free influenza vaccine
Chaeyeon Lee et al.
BIOMATERIALS (2018)
Multivalent and multifunctional polysaccharide-based particles for controlled receptor recognition
Haohao Duan et al.
SCIENTIFIC REPORTS (2018)
Vaccine development for human mastadenovirus
Shiying Chen et al.
JOURNAL OF THORACIC DISEASE (2018)
Alveolar Macrophages in the Resolution of Inflammation, Tissue Repair, and Tolerance to Infection
Benoit Allard et al.
FRONTIERS IN IMMUNOLOGY (2018)
Universal influenza vaccines: from viruses to nanoparticles
Ye Wang et al.
EXPERT REVIEW OF VACCINES (2018)
Advances and Challenges in Nanomedicine
Susan Hua et al.
FRONTIERS IN PHARMACOLOGY (2018)
Nanoparticle Vaccines Against Infectious Diseases
Rashmirekha Pati et al.
FRONTIERS IN IMMUNOLOGY (2018)
Transmission and Control of Respiratory Viral Infections in the Healthcare Setting
Pablo E. Bonvehi et al.
CURRENT TREATMENT OPTIONS IN INFECTIOUS DISEASES (2018)
Cilia and Mucociliary Clearance
Ximena M. Bustamante-Marin et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Biodegradable nanoparticle delivery of inactivated swine influenza virus vaccine provides heterologous cell-mediated immune response in pigs
Santosh Dhakal et al.
JOURNAL OF CONTROLLED RELEASE (2017)
ICTV Virus Taxonomy Profile: Pneumoviridae
Bert Rima et al.
JOURNAL OF GENERAL VIROLOGY (2017)
Mucosal vaccination of conserved sM2, HA2 and cholera toxin subunit Al (CTAI) fusion protein with poly gamma-glutamate/chitosan nanoparticles (PC NPs) induces protection against divergent influenza subtypes
Mohammed Y. E. Chowdhury et al.
VETERINARY MICROBIOLOGY (2017)
Targeting Pattern Recognition Receptors (PRR) for Vaccine Adjuvantation: From Synthetic PRR Agonists to the Potential of Defective Interfering Particles of Viruses
Andri Vasou et al.
VIRUSES-BASEL (2017)
A comparative review of viral entry and attachment during large and giant dsDNA virus infections
Haitham Sobhy
ARCHIVES OF VIROLOGY (2017)
PEGylation of a TLR2-agonist-based vaccine delivery system improves antigen trafficking and the magnitude of ensuing antibody and CD8+ T cell responses
Toshiki Sekiya et al.
BIOMATERIALS (2017)
Thermoresponsive Polymer Nanoparticles Co-deliver RSV F Trimers with a TLR-7/8 Adjuvant
Joseph R. Francica et al.
BIOCONJUGATE CHEMISTRY (2016)
The Interaction between Respiratory Pathogens and Mucus
Mark Zanin et al.
CELL HOST & MICROBE (2016)
Control of lung defence by mucins and macrophages: ancient defence mechanisms with modern functions
William J. Janssen et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers
Susanne Schoettler et al.
NATURE NANOTECHNOLOGY (2016)
Human Influenza Virus Infections
Christin Peteranderl et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Parainfluenza Virus Infection
Angela R. Branche et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity
A. L. Silva et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Combination Nanovaccine Demonstrates Synergistic Enhancement in Efficacy against Influenza
Kathleen Ross et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2016)
Combination Nanovaccine Demonstrates Synergistic Enhancement in Efficacy against Influenza
Kathleen Ross et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2016)
Recent Advances in Subunit Vaccine Carriers
Abhishek Vartak et al.
VACCINES (2016)
Human Adenovirus Associated with Severe Respiratory Infection, Oregon, USA, 2013-2014
Magdalena Kendall Scott et al.
EMERGING INFECTIOUS DISEASES (2016)
mRNA vaccine delivery using lipid nanoparticles
Andreas M. Reichmuth et al.
THERAPEUTIC DELIVERY (2016)
Viral entry pathways: the example of common cold viruses
Dieter Blaas
WIENER MEDIZINISCHE WOCHENSCHRIFT (2016)
Addressing viral resistance through vaccines
Catherine Laughlin et al.
FUTURE VIROLOGY (2015)
Respiratory nanoparticle-based vaccines and challenges associated with animal models and translation
Gourapura J. Renukaradhya et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Moderate PEGylation of the carrier protein improves the polysaccharide-specific immunogenicity of meningococcal group A polysaccharide conjugate vaccine
Tingting Zhang et al.
VACCINE (2015)
Dynamics of Virus-Receptor Interactions in Virus Binding, Signaling, and Endocytosis
Steeve Boulant et al.
VIRUSES-BASEL (2015)
The potential of nanoparticles for the immunization against viral infections
Viktoriya Sokolova et al.
JOURNAL OF MATERIALS CHEMISTRY B (2015)
Molecular pathology of emerging coronavirus infections
Lisa E. Gralinski et al.
JOURNAL OF PATHOLOGY (2015)
Polysaccharides: Candidates of promising vaccine adjuvants
Pingli Li et al.
DRUG DISCOVERIES AND THERAPEUTICS (2015)
Chitosan Nanoparticle Encapsulated Hemagglutinin-Split Influenza Virus Mucosal Vaccine
Chompoonuch Sawaengsak et al.
AAPS PHARMSCITECH (2014)
Carrier interactions with the biological barriers of the lung: Advanced in vitro models and challenges for pulmonary drug delivery
Cristiane de Souza Carvalho et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery
Vincent Pavot et al.
NANOMEDICINE (2014)
Intranasal delivery of nanoparticles encapsulating BPI3V proteins induces an early humoral immune response in mice
Fawad Mansoor et al.
RESEARCH IN VETERINARY SCIENCE (2014)
Endocytosis of Viruses and Bacteria
Pascale Cossart et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
An Overview of Respiratory Syncytial Virus
Jia Meng et al.
PLOS PATHOGENS (2014)
Self-replicating Replicon-RNA Delivery to Dendritic Cells by Chitosan-nanoparticles for Translation In Vitro and In Vivo
Kenneth C. McCullough et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Nanotechnology and vaccine development
Mi-Gyeong Kim et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Overcoming the pulmonary barrier: new insights to improve the efficiency of inhaled therapeutics
Xabi Murgia et al.
EUROPEAN JOURNAL OF NANOMEDICINE (2014)
Etiology and Clinical Outcomes of Acute Respiratory Virus Infection in Hospitalized Adults
Yu Bin Seo et al.
INFECTION AND CHEMOTHERAPY (2014)
Traditional and New Influenza Vaccines
Sook-San Wong et al.
CLINICAL MICROBIOLOGY REVIEWS (2013)
Advances in antiviral vaccine development
Barney S. Graham
IMMUNOLOGICAL REVIEWS (2013)
Alginate Nanoparticles as a Promising Adjuvant and Vaccine Delivery System
F. Sarei et al.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Development of a nanoparticle-based influenza vaccine using the PRINT® technology
Ashley L. Galloway et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2013)
Multiscale perspectives of virus entry via endocytosis
Eric Barrow et al.
VIROLOGY JOURNAL (2013)
Chitosan-based drug delivery systems
Andreas Bernkop-Schnuerch et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2012)
Chitosan-based delivery systems for mucosal vaccines
Inderjit Jabbal-Gill et al.
EXPERT OPINION ON DRUG DELIVERY (2012)
Mucociliary clearance of micro- and nanoparticles is independent of size, shape and charge-an ex vivo and in silico approach
Julian Kirch et al.
JOURNAL OF CONTROLLED RELEASE (2012)
PLGA-based nanoparticles: An overview of biomedical applications
Fabienne Danhier et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Immunogenicity and protection of oral influenza vaccines formulated into microparticles
Prathap Nagaraja Shastri et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Effect of the Poly(ethylene glycol) (PEG) Density on the Access and Uptake of Particles by Antigen-Presenting Cells (APCs) after Subcutaneous Administration
Xi Zhan et al.
MOLECULAR PHARMACEUTICS (2012)
Translational research in infectious disease: current paradigms and challenges ahead
Judith M. Fontana et al.
TRANSLATIONAL RESEARCH (2012)
Pathogenesis of acute respiratory illness caused by human parainfluenza viruses
Henrick Schomacker et al.
CURRENT OPINION IN VIROLOGY (2012)
The Airway Epithelium: Soldier in the Fight against Respiratory Viruses
Marjolaine Vareille et al.
CLINICAL MICROBIOLOGY REVIEWS (2011)
Programming the magnitude and persistence of antibody responses with innate immunity
Sudhir Pai Kasturi et al.
NATURE (2011)
Progress in Respiratory Virus Vaccine Development
Alexander C. Schmidt
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Hirenkumar K. Makadia et al.
POLYMERS (2011)
A Dilemma for Viruses and Giant Viruses: Which Endocytic Pathway to Use to Enter Cells?
Eric Ghigo
INTERVIROLOGY (2010)
Nanoparticle vaccines against respiratory viruses
Brian M. Adair
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2009)
Treatment of respiratory virus infections
Yacine Abed et al.
ANTIVIRAL RESEARCH (2006)
Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus
SR Weiss et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2005)
Lung defences: an overview
L. P. Nicod
EUROPEAN RESPIRATORY REVIEW (2005)
Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene
WD Zhang et al.
NATURE MEDICINE (2005)
Virus entry: Molecular mechanisms and biomedical applications
DS Dimitrov
NATURE REVIEWS MICROBIOLOGY (2004)
Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children
RB Belshe et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
分享论文
